XBiotech (XBIT) Non Operating Income (2014 - 2026)
XBiotech (XBIT) posted quarterly Non Operating Income of $141000.0 for Q3 2025, up 169.46% year-over-year from $52327.2 in Q3 2024, and down 96.94% quarter-over-quarter from $4.6 million in Q2 2025.
XBiotech (XBIT) Non Operating Income (2014 - 2026) Analysis & Trends
XBiotech's Non Operating Income history runs 12 years deep, the most recent figure standing at $141000.0 for Q3 2025.
- In Q3 2025, Non Operating Income rose 169.46% year-over-year to $141000.0; the TTM figure through Dec 2025 stood at $4.7 million (up 477.57% YoY), while the FY2025 annual figure was -$88000.0, down 102.25% from the prior year.
- Non Operating Income for Q3 2025 stood at $141000.0, down from $4.6 million in the prior quarter.
- The five-year high for Non Operating Income was $13.2 million in Q4 2023, with the low at -$3.9 million in Q3 2022.
- The 5-year median for Non Operating Income is $876000.0 (2024), against an average of $1.5 million.
- Peak annual rise in Non Operating Income reached 1268.14% in 2022, while the deepest fall reached 336.11% in 2022.
- XBiotech's Non Operating Income stood at -$474000.0 in 2021, then surged by 1268.14% to $5.5 million in 2022, then soared by 138.34% to $13.2 million in 2023, then tumbled by 113.65% to -$1.8 million in 2024, then soared by 107.83% to $141000.0 in 2025.
- Business Quant data shows XBIT's Non Operating Income at $141000.0 in Q3 2025, $4.6 million in Q2 2025, and -$88000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -53.64 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -51.63 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | -536,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -536,000.00 |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 141,000.00 |
| Jun 30, 2025 | 4.61 Mn |
| Mar 31, 2025 | -88,000.00 |
| Dec 31, 2024 | -1.80 Mn |
| Sep 30, 2024 | -203,000.00 |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | 876,000.00 |
| Dec 31, 2023 | 13.20 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 3.29 Mn |
| Dec 31, 2022 | 5.54 Mn |
| Sep 30, 2022 | -3.87 Mn |
| Jun 30, 2022 | -2.16 Mn |
| Mar 31, 2022 | 1.39 Mn |
| Dec 31, 2021 | -474,000.00 |
| Sep 30, 2021 | -1.32 Mn |
| Jun 30, 2021 | 914,000.00 |